Literature DB >> 22621960

Identification of permissive insertion sites for generating functional fluorescent mineralocorticoid receptors.

Cristina Aguilar-Sánchez1, Iván Hernández-Díaz, Fabián Lorenzo-Díaz, Juan F Navarro, Thom E Hughes, Teresa Giraldez, Diego Alvarez de la Rosa.   

Abstract

The mineralocorticoid receptor (MR), a member of the nuclear receptor superfamily of transcription factors, is activated by aldosterone and mediates its natriferic action in tight epithelia. MR is also expressed in nonepithelial tissues. Importantly, it mediates the deleterious effects of inappropriately high aldosterone levels in the heart, in which it induces the development of cardiac fibrosis. Antagonism of MR in humans is useful in the treatment of severe cardiac failure and some forms of hypertension. Despite the important pathophysiological and pharmacological role of this receptor, many important questions about its cellular biology and functional roles remain unanswered. A major challenge in the study of MR is the unavailability of fully functional fluorescent derivatives of the receptor. In this study we have created a library of MR mutants with insertions of the yellow fluorescent protein in various internal locations in the receptor using a random-insertion transposon-based technique. Screening of this library using a transactivation assay allowed us to identify several fluorescent constructs that retain functionality. Detailed characterization of one of these construct showed that it induces aldosterone-target genes such as the epithelial Na(+) channel subunits and the serum and glucocorticoid-induced kinase 1 at physiological concentrations of aldosterone to an equal extent than the wild-type receptor. Furthermore, aldosterone affinity, hormone-induced nuclear translocation, DNA binding and regulation of nongenomic pathways are all indistinguishable from the wild-type receptor. This new set of fluorescent MR derivatives provides a useful tool for studying the cell biology of the receptor.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22621960     DOI: 10.1210/en.2012-1210

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  4 in total

1.  Phosphorylation of Mineralocorticoid Receptor Ligand Binding Domain Impairs Receptor Activation and Has a Dominant Negative Effect over Non-phosphorylated Receptors.

Authors:  Rubén Jiménez-Canino; Miguel X Fernandes; Diego Alvarez de la Rosa
Journal:  J Biol Chem       Date:  2016-07-15       Impact factor: 5.157

2.  Epidermal glucocorticoid and mineralocorticoid receptors act cooperatively to regulate epidermal development and counteract skin inflammation.

Authors:  Judit Bigas; Lisa M Sevilla; Elena Carceller; Julia Boix; Paloma Pérez
Journal:  Cell Death Dis       Date:  2018-05-22       Impact factor: 8.469

3.  Glucocorticoid Receptor-Tethered Mineralocorticoid Receptors Increase Glucocorticoid-Induced Transcriptional Responses.

Authors:  Caroline A Rivers; Mark F Rogers; Felicity E Stubbs; Becky L Conway-Campbell; Stafford L Lightman; John R Pooley
Journal:  Endocrinology       Date:  2019-05-01       Impact factor: 4.736

4.  The diuretic torasemide does not prevent aldosterone-mediated mineralocorticoid receptor activation in cardiomyocytes.

Authors:  Basile Gravez; Antoine Tarjus; Ruben Jimenez-Canino; Soumaya El Moghrabi; Smail Messaoudi; Diego Alvarez de la Rosa; Frederic Jaisser
Journal:  PLoS One       Date:  2013-09-09       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.